U.S. FDA OKs new generation Boston Scientific heart pacing devices

April 15 (Reuters) - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.